Position in BMY
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$265,340
+$43,604 QoQ
Shares Held
4,605
+26.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#1,951
of 2,506 holders
Holding Since
Mar 2024
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Fragasso Financial Advisors Inc holds $24,423,418 across 9 Drug Manufacturers - General names. BMY ranks #8 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
25,026 | $6,355,853 | |
| 2 | LLY |
ELI LILLY & Co
|
4,609 | $5,528,173 | |
| 3 | ABBV |
AbbVie Inc.
|
21,001 | $5,284,691 | |
| 4 | AMGN |
Amgen Inc
|
11,714 | $4,241,873 | |
| 5 | MRK |
Merck & Co., Inc.
|
12,421 | $1,596,098 | |
| 6 | PFE |
Pfizer Inc
|
22,006 | $529,904 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
2,989 | $377,630 | |
| 8 | BMY |
Bristol Myers Squibb Co
This page
|
4,605 | $265,340 |
All Filings in BMY
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $265,340 | 4,605 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $221,736 | 3,656 | Shares | Sole | 2026-04-07 | |
| 2025-03-31 | $208,036 | 3,411 | Shares | Sole | 2025-04-09 | |
| 2024-03-31 | $238,828 | 4,404 | Shares | Sole | 2024-04-10 | |
| No filing history on record for this holder in this stock. | ||||||